Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: a structural equation modeling approach.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Psychoneuroendocrinology

• Publication date

  2014-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psyneuen.2014.07.019PMID 25199983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment.

  2013cited by this paper
• Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.

  2013cited by this paper
• Schizophrenia with preserved insight is associated with increased perfusion of the precuneus.

  2012cited by this paper
• Relationship between metabolic syndrome and cognition in patients with schizophrenia.

  2012cited by this paper
• Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

  2012cited by this paper
• Leber's hereditary optic neuropathy associated with schizophrenia.

  2012cited by this paper
• Obesity and Metabolic Syndrome and Functional and Structural Brain Impairments in Adolescence

  2012cited by this paper
• Neurocognition, Insight and Medication Nonadherence in Schizophrenia: A Structural Equation Modeling Approach

  2012cited by this paper
• Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia.

  2012cited by this paper
• Are Cardiovascular Risk Factors Associated with Verbal Learning and Memory Impairment in Patients with Schizophrenia? A Cross-Sectional Study

  2012cited by this paper
• The puzzle of schizophrenia: Tracking the core role of cognitive deficits

  2012cited by this paper
• Cognitive remediation therapy for eating disorders: development, refinement and future directions.

  2011cited by this paper
• Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis

  2011cited by this paper
• Obesity, orbitofrontal structure and function are associated with food choice: a cross-sectional study

  2011cited by this paper
• Elevated BMI Is Associated With Decreased Blood Flow in the Prefrontal Cortex Using SPECT Imaging in Healthy Adults

  2011cited by this paper
• Metabolic syndrome: definitions and controversies

  2011cited by this paper
• Resting State Functional Connectivity in Perfusion Imaging: Correlation Maps with BOLD Connectivity and Resting State Perfusion

  2011cited by this paper
• The effects of hypertension and body mass index on cognition in schizophrenia.

  2010cited by this paper
• Linkage of cognitive impairments with metabolic disorders in schizophrenia.

  2010cited by this paper
• Impaired modulation of attention and emotion in schizophrenia.

  2010cited by this paper
• Metabolic Syndrome Is Associated with Learning and Recall Impairment in Middle Age

  2010cited by this paper
• The interaction of working memory and emotion in persons clinically at risk for psychosis: an fMRI pilot study.

  2010cited by this paper
• Serum leptin level and cognition in the elderly: Findings from the Health ABC Study.

  2009cited by this paper
• Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition.

  2009cited by this paper
• Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults

  2008cited by this paper
• Longitudinal studies of cognition in schizophrenia: Meta-analysis

  2008cited by this paper
• Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes.

  2008cited by this paper
• Orbitofrontal volume deficit in schizophrenia and thought disorder.

  2007cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cited by this paper
• Understanding the mechanisms of food intake and obesity

  2007cited by this paper
• Cognitive inhibition in patients with medial orbitofrontal damage

  2007cited by this paper
• Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats.

  2006cited by this paper
• Orbitofrontal cortex, decision-making and drug addiction.

  2006cited by this paper
• Prefrontal cognitive functions in stabilized first-episode patients with schizophrenia spectrum disorders: a dissociation between dorsolateral and orbitofrontal functioning.

  2005cited by this paper
• The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• An fMRI study of the Trail Making Test.

  2005cited by this paper
• Identification of separable cognitive factors in schizophrenia.

  2004cited by this paper
• The metabolic syndrome, inflammation, and risk of cognitive decline.

  2004cited by this paper
• Cognitive Functioning Predicts Outpatient Service Utilization in Schizophrenia

  2004cited by this paper
• Obesity is a chronic, relapsing neurochemical disease

  2004cited by this paper
• Cognitive deficits as treatment targets in schizophrenia.

  2004cited by this paper
• General and specific cognitive deficits in schizophrenia.

  2003cited by this paper
• Reducing global risk for cardiovascular disease: Using lifestyle changes and pharmacotherapy

  2002cited by this paper
• Hemispheric asymmetry in human lateral prefrontal cortex during cognitive set shifting

  2002cited by this paper
• Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents.

  2002cited by this paper
• Neuroimaging and Obesity

  2002cited by this paper
• LISREL Approaches to Interaction Effects in Multiple Regression

  1998cited by this paper
• Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

  1998cited by this paper
• LISREL analyses of interaction effects in multiple regression

  1996cited by this paper
• DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

  1994cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• Assessing Depression in Schizophrenia: The Calgary Depression Scale

  1993cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Significance of Positive and Negative Syndromes in Chronic Schizophrenia

  1986cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper

• The role of anti-inflammatory diets and supplementation in metabolic syndrome and symptom remission in adults with schizophrenia: a systematic review

  2025cites this paper
• MRI-based insights into brain structural and functional alterations in schizophrenia treated with risperidone

  2025cites this paper
• Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise

  2024cites this paper
• Alterations in regional homogeneity in schizophrenia patients comorbid with metabolic syndrome treated with risperidone or clozapine.

  2024cites this paper
• The Predictive Role of Aberrant Metabolic Parameters and Negative Automatic Thinking on the Cognitive Impairments Among Schizophrenia Patients with Metabolic Syndrome

  2022cites this paper
• Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments

  2022cites this paper
• Metabolic disturbances, hemoglobin A1c, and social cognition impairment in Schizophrenia spectrum disorders

  2022cites this paper
• Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.

  2021cites this paper
• Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex

  2021cites this paper
• Metabolic Syndrome and Cognitive Functions in Schizophrenia—Implementation of Dietary Intervention

  2020cites this paper
• Dietary Behaviors and Metabolic Syndrome in Schizophrenia Patients

  2020cites this paper
• The correlation between metabolic syndrome and neurocognitive and social cognitive performance of patients with schizophrenia.

  2020cites this paper
• Effect of comorbid metabolic syndrome and related components on cognition in patients with schizophrenia

  2019cites this paper
• Reward‐related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome

  2018cites this paper
• Analyzing the neuropsychological characteristics and changes in serum markers of patients with chronic cerebral circulation insufficiency.

  2018cites this paper
• Test–Retest Reliability and Minimal Detectable Change of the D2 Test of Attention in Patients with Schizophrenia

  2018cites this paper
• Neurovascular Unit Dysfunction and Blood–Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence

  2017cites this paper
• Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?

  2017cites this paper
• Functional brain substrate of quality of life in patients with schizophrenia: A brain SPECT multidimensional analysis.

  2016cites this paper
• The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis

  2016cites this paper
• Potentially inappropriate psychotropic prescription at discharge is associated with lower functioning in the elderly psychiatric inpatients. A cross-sectional study

  2016cites this paper
• A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.

  2016cites this paper
• Metabolic syndrome in schizophrenia patients associated with poor premorbid school performance in early adolescence

  2016cites this paper
• Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.

  2016cites this paper
• ESTUDO DE PADRONIZAÇÃO, VALIDADE E PRECISÃO DO TESTE DE ATENÇÃO CONCENTRADA d2-R (VERSÃO ORIGINAL)

  2016cites this paper
• Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.

  2016cites this paper
• Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study

  2015cites this paper
• Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study

  2015cites this paper
• Association of metabolic syndrome with sensory gating deficits in patients with chronic schizophrenia.

  2015cites this paper
• EPA-0395 – Metabolic Alterations Associated with First and Second Generation Antipsychotics: an Twenty-years Open Study

  2014cites this paper